Keystone: Diagnosis and Model Treatments for Traumatic Brain Injury
Identifying injuries that might lead to chronic traumatic encephalopathy or other neurodegenerative pathologies, and then treating those injuries, are two major challenges...
ALL NEWS
5781 RESULTS
Sort By:
- Most Recent
- Most Commented
Biomarker Progress? Picking the New, Better Measuring the Old
Individual labs are experimenting trying to improve the differential diagnoses of related dementias...
Research Brief: Another Worker Contributes to Axon Stability
Building a healthy axon, like erecting a skyscraper, takes a variety of workers and materials...
Neurofilaments May Be Essential to Some Tauopathies
It appears that some tauopathies require the presence of neurofilaments for neurodegeneration to occur. In the 15 August Journal of Neuroscience, Virginia Lee, Takeshi Ishihara, and colleagues at the University of Pennsylvania describe...
$2.34 Billion Alzheimer’s Budget Signed Into Law
The bill tops last year’s budget for the disease by $425 million.
Research Brief: The RNA World Expands, Again
After messenger RNA, there were microRNAs, and with them the growth and development of cells and organisms...
ALS on a Chip—A Model for Screening Therapeutics?
Neuromuscular junctions between human stem cell-derived motor neurons and skeletal muscle fibers faltered when cells came from an ALS patient.
High-Resolution Map of Hippocampus Reveals Multiple Subnetworks
The most detailed look yet at hippocampal wiring may guide future functional studies and disease research.
Getting Between Fibrin and Complement Receptor Cools Inflammation
An antibody that binds fibrin blocks neuro-inflammatory signaling while allowing normal clotting.
African-American Participation in AD Research: Effective Strategies
Alzheimer’s Researchers Seek Advice on How to Include African-Americans Do African-Americans Have More, or Different, Alzheimer’s Disease? Too Little Data to Tell Is Alzheimer’s more common, or different, in black Americans? Or do cerebrovascular risk ...
Do African-Americans Have More, or Different, Alzheimer’s Disease? Too Little Data to Tell
At a workshop on engaging more black Americans in ADRD research, new CSF findings stood out against a general dearth of data on Alzheimer’s disease in underrepresented minorities.
Alzheimer’s Researchers Seek Advice on How to Include African-Americans
Despite having a higher incidence of Alzheimer’s or a related dementia, relatively few black people participate in research studies or drug trials. How to achieve full representation?
Anti-Amyloid Drug Pipeline Shows No Sign of Drying Up
Researchers at AD/PD 2017 presented new data on an antibody and small molecules targeting amyloid.
More Private Funding for Alzheimer’s Research
New awards plow $5 million into synthesizing published AD data and $6 million into early stage clinical trials.
PSP & CBD International Research Symposium 2018
International Symposium Puts PSP/CBD on the Map Can Clinical Trials and Longitudinal Studies Crack Rare Tauopathies? Tufted astrocytes? Astrocytic plaques? These tau pathologies mark progressive supranuclear palsy and corticobasal degeneration, ...
Current Filters
- Date Range : All x